Trial Details

COMPLETED
Basic Information
Clinical ID c553
Identifier NCT04577794
Trial Title A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Ulcerative Colitis
Interventions DRUG: GLPG3970|DRUG: Placebo
Participant Information
Sponsor Galapagos NV
City Tbilisi
Country/Region Georgia
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2020-10-05
Primary Completion Date 2021-05-17
Completion Date 2021-05-31